Rocket One Inc. Net Change in Cash
Rocket One Inc. (RKTO) reported Net Change in Cash of $6.62 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-05-15
- Rocket One Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $6.62M.
- Rocket One Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$2.16M, a 112.97% decline year-over-year.
- Rocket One Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was $16.67M, a 526.88% increase year-over-year.
- Rocket One Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was $2.66M.
- Rocket One Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$2.10M, a 135.36% decline from fiscal 2021.
- Rocket One Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $5.94M, a 687.53% increase from fiscal 2020.
- Rocket One Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $754.15K, a 53.11% decline from fiscal 2019.
- Rocket One Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was $1.61M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-03-31 | $6.62M 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | -$2.10M 10-K · filed 2023-03-31 | ||||||
| 2022-09-30 | $406.51K 10-Q · filed 2022-11-10 | ||||||
| 2022-06-30 | $2.79M 10-Q · filed 2022-08-12 | ||||||
| 2022-03-31 | -$2.16M 10-Q · filed 2023-05-15 | ||||||
| 2021-12-31 | $5.94M 10-K · filed 2023-03-31 | ||||||
| 2021-09-30 | $9.86M 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | $13.24M 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | $16.67M 10-Q · filed 2022-05-12 | $16.67M 10-Q · filed 2021-05-13 | |||||
| 2020-12-31 | $754.15K 10-K · filed 2022-03-30 | $738.80K 10-K · filed 2021-03-16 | |||||
| 2020-09-30 | $2.23M 10-Q · filed 2021-11-10 | $2.23M 10-Q · filed 2020-11-10 | |||||
| 2020-06-30 | $3.06M 10-Q · filed 2021-08-11 | ||||||
| 2020-03-31 | $2.66M 10-Q · filed 2021-05-13 | ||||||
| 2019-12-31 | $1.61M 10-K · filed 2021-03-16 | ||||||
| 2019-09-30 | $3.13M 10-Q · filed 2020-11-10 | ||||||
| 2019-06-30 | $4.01M 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |